Indivior Pharmaceuticals Ratios (2021-2026) | INDV

Ratios Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 86.62%73.58%78.50%83.61%83.08%82.78%73.25%81.56%87.38%
EBT Margin (Quarter) 25.70%-40.47%9.77%12.71%22.18%20.53%11.78%22.63%36.28%
EBIT Margin (Quarter) 26.41%-39.46%11.40%15.38%24.81%23.84%13.69%22.63%43.22%
EBITDA Margin (Quarter) 20.77%-32.44%11.40%15.38%18.42%6.62%13.69%22.63%43.22%
Operating Margin (Quarter) 26.41%-39.46%11.40%15.38%24.81%23.84%13.69%22.63%43.22%
Net Margin (Quarter) 21.83%-32.78%7.17%7.02%18.05%5.96%13.38%28.49%28.08%
FCF Margin (Quarter) -13.73%28.09%-1.63%-11.04%26.32%46.69%-18.79%-68.44%-9.15%
Efficiency
Inventory Average (Quarter) 104.50M120.00M165.00M156.00M152.00M154.00M152.50M
Assets Average (Quarter) 2,685.00M1,542.50M1,345.50M1,413.50M1,434.00M1,308.50M1,199.00M
Equity Average (Quarter) 53.00M-99.50M-172.50M-221.00M-295.50M-323.50M-311.00M-271.00M-232.00M-152.50M-121.00M
Invested Capital (Quarter) 437.00M309.00M56.00M-161.00M-281.00M-310.00M-4.00M-267.00M-239.00M-189.00M-69.00M-144.00M
Asset Utilization Ratio (Quarter) 0.770.870.830.820.951.08
Leverage & Solvency
Interest Coverage Ratio (Quarter) 8.33-13.113.183.545.504.803.5813.5019.57
Debt to Equity (Quarter) 2.00-16.00-1.30-0.99-1.15-1.27-1.56-3.26-3.38
Debt Ratio (Quarter) 0.130.140.140.250.240.220.230.270.41
Equity Ratio (Quarter) 0.07-0.01-0.10-0.26-0.21-0.18-0.15-0.08-0.12
Times Interest Earned (Quarter) 8.33-13.113.183.545.504.803.5813.5019.57
Valuation
Enterprise Value (Quarter) -1102.00M-893.00M-731.00M-320.00M-373.00M-510.00M-445.00M-195.00M-175.00M
Return Ratios
Return on Sales (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter) 6.14%8.52%61.26%48.40%66.41%79.29%
Return on Invested Capital (Quarter) 0.00%0.00%0.00%-0.01%-0.02%-0.03%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.02%